Hematopoietic Prostaglandin D2 Synthase Controls Tfh/Th2 Communication and Limits Tfh Antitumor Effects

Archive ouverte

Mary, Romain | Chalmin, Fanny | Accogli, Théo | Bruchard, Mélanie | Hibos, Christophe | Melin, Joséphine | Truntzer, Caroline | Limagne, Emeric | Derangère, Valentin | Thibaudin, Marion | Humblin, Etienne | Boidot, Romain | Chevrier, Sandy | Arnould, Laurent | Richard, Corentin | Klopfenstein, Quentin | Bernard, Antoine | Urade, Yoshihiro | Harker, James | Apetoh, Lionel | Ghiringhelli, François | Végran, Frédérique

Edité par CCSD ; American Association for Cancer Research -

International audience. Abstract T follicular helper (Tfh) cells are a subset of CD4+ T cells essential in immunity and have a role in helping B cells produce antibodies against pathogens. However, their role during cancer progression remains unknown. The mechanism of action of Tfh cells remains elusive because contradictory data have been reported on their protumor or antitumor responses in human and murine tumors. Like Tfh cells, Th2 cells are also involved in humoral immunity and are regularly associated with tumor progression and poor prognosis, mainly through their secretion of IL4. Here, we showed that Tfh cells expressed hematopoietic prostaglandin D2 (PGD2) synthase in a pSTAT1/pSTAT3-dependent manner. Tfh cells produced PGD2, which led to recruitment of Th2 cells via the PGD2 receptor chemoattractant receptor homologous molecule expressed on Th type 2 cells (CRTH2) and increased their effector functions. This cross-talk between Tfh and Th2 cells promoted IL4-dependent tumor growth. Correlation between Th2 cells, Tfh cells, and hematopoietic PGD2 synthase was observed in different human cancers and associated with outcome. This study provides evidence that Tfh/Th2 cross-talk through PGD2 limits the antitumor effects of Tfh cells and, therefore, could serve as a therapeutic target.

Consulter en ligne

Suggestions

Du même auteur

The tumor microenvironment impairs Th1 IFNγ secretion through alternative splicing modifications of Irf1 pre-mRNA

Archive ouverte | Bernard, Antoine | CCSD

International audience. Abstract It is clearly established that the immune system can affect cancer response to therapy. However, the influence of the tumor microenvironment (TME) on immune cells is not completely u...

Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses

Archive ouverte | Bruchard, Mélanie | CCSD

International audience

Sirtuin-1 Activation Controls Tumor Growth by Impeding Th17 Differentiation via STAT3 Deacetylation.

Archive ouverte | Limagne, Emeric | CCSD

International audience. Sirtuin-1 deacetylates proteins and has emerged as a critical regulator of different cellular processes, particularly inflammation. Basal SIRT1 activity was previously found to limit Th9 and ...

Chargement des enrichissements...